These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 17079318)

  • 1. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.
    Cornberg M; Sheridan BS; Saccoccio FM; Brehm MA; Selin LK
    J Virol; 2007 Jan; 81(2):934-44. PubMed ID: 17079318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Private specificities of CD8 T cell responses control patterns of heterologous immunity.
    Kim SK; Cornberg M; Wang XZ; Chen HD; Selin LK; Welsh RM
    J Exp Med; 2005 Feb; 201(4):523-33. PubMed ID: 15710651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
    Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
    J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
    Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
    J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens.
    Brehm MA; Pinto AK; Daniels KA; Schneck JP; Welsh RM; Selin LK
    Nat Immunol; 2002 Jul; 3(7):627-34. PubMed ID: 12055626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparate epitopes mediating protective heterologous immunity to unrelated viruses share peptide-MHC structural features recognized by cross-reactive T cells.
    Shen ZT; Nguyen TT; Daniels KA; Welsh RM; Stern LJ
    J Immunol; 2013 Nov; 191(10):5139-52. PubMed ID: 24127554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation.
    Kim SK; Brehm MA; Welsh RM; Selin LK
    J Immunol; 2002 Jul; 169(1):90-8. PubMed ID: 12077233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
    Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
    Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
    Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
    J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequencies of virus-specific CD8+ T-cell precursors.
    Seedhom MO; Jellison ER; Daniels KA; Welsh RM
    J Virol; 2009 Dec; 83(24):12907-16. PubMed ID: 19812167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-priming of a single viral protein from lymphocytic choriomeningitis virus alters immunodominance hierarchies of CD8+ T cells during subsequent viral infections.
    Dunbar E; Alatery A; Basta S
    Viral Immunol; 2007 Dec; 20(4):585-98. PubMed ID: 18158732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity.
    Nie S; Cornberg M; Selin LK
    J Immunol; 2009 Nov; 183(10):6554-60. PubMed ID: 19846867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8 T cell-mediated, TNF-dependent immunopathology.
    Liu F; Feuer R; Hassett DE; Whitton JL
    J Clin Invest; 2006 Feb; 116(2):465-75. PubMed ID: 16424939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to visualize polyclonal virus-specific CD8 T cells in vivo.
    Zimmermann C; Pircher H
    J Immunol; 1999 May; 162(9):5178-82. PubMed ID: 10227990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.
    Selin LK; Vergilis K; Welsh RM; Nahill SR
    J Exp Med; 1996 Jun; 183(6):2489-99. PubMed ID: 8676069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral immunity against vaccinia virus infection of mice.
    Xu R; Johnson AJ; Liggitt D; Bevan MJ
    J Immunol; 2004 May; 172(10):6265-71. PubMed ID: 15128815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection.
    Decman V; Laidlaw BJ; Dimenna LJ; Abdulla S; Mozdzanowska K; Erikson J; Ertl HC; Wherry EJ
    J Immunol; 2010 May; 184(9):5151-9. PubMed ID: 20368274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization.
    Hassett DE; Slifka MK; Zhang J; Whitton JL
    J Virol; 2000 Sep; 74(18):8286-91. PubMed ID: 10954526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.